Clinical Trial Update: Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This Phase 1 trial studied a combination of tipifarnib, cytarabine, and daunorubicin in older patients with acute myeloid leukemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Tipifarnib (tipifarnib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Leukemia | Phase 1 | Status: COMPLETED